Factors influencing kidney cancer outcomes with immunotherapy
This video interview discusses the effect of certain factors such [...]
How time of day of immunotherapy infusion affects kidney cancer outcomes
Recent studies have suggested that the time of day when [...]
TKI treatment breaks may not affect outcomes in kidney cancer
The results of the phase 2/3 STAR trial were published [...]
BMI and outcomes in patients with metastatic kidney cancer treated with first-line TKIs
This study looked at whether high or low body mass [...]
Papillary type I vs type II renal cell carcinoma
Papillary renal cell carcinoma (pRCC) is the second most common [...]
Artificial intelligence for kidney cancer diagnosis
In a presentation at the 19th Meeting of the European Association [...]
ESMO 2021: Cancer and COVID-19: Outcomes and risk factors
This year there was some very important data presented at [...]
Association of immune-related adverse events and outcomes in kidney cancer
Previous studies have shown that cancer patients who experience immune-related [...]
Patterns of metastases for clear cell, papillary and chromophobe RCC associated with survival
A recent study published in JAMA Network Open looked at [...]
Most coronavirus-positive cancer patients are asymptomatic
Most studies have shown that many cancer patients are at [...]
